Sands Expo and Convention Centre expects about 1000 people to attend the conference Biologics Manufacturing Asia. 役立ちます イベントに参加する予定の出展者は何社ですか? イベントではどのような種類の製品/サービスが紹介されますか? イベントに参加する講演者のリストを入手できますか?
2024年9月10日-11日,澳斯康生物制药将出席参加于新加坡举办的Biologics Contract Manufacturing Asia 2024国际会议,该会专注于生物制药CMO,是亚太地区最受关注的生物制药大会,预计将有300+专业参会者,120+机构,40+专家发言。 澳斯康生物集团董事长兼总裁罗顺博士将在大会进行2场专场演讲和1场圆桌讨论,与到场的国际嘉...
12th Biologics Manufacturing Asia 2025, 12-13 Mar 2025, Singapore, organized by IMAPAC Pte Ltd. Find conference details | Conference Locate (Clocate)
From €5408 Biologics Market - Forecasts from 2024 to 2029 Report 121 Pages April 2024 Global From €3892 Biologics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Product, Application, Source, Manufacturing and Geography ...
Singapore, March 21, 2024– WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it received four awards at the 2024 Asia-Pacific Biopharma Excellence Awards (ABEA
Welcome to KGbio - Clinical-stage biotech company Backed by Kalbe and Genexine and US private equity giant General Atlantic. Licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas and also contract manufacturing.
With over 12,000 skilled employees inChina,the United States,Ireland,GermanyandSingapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As ofJune 30, 2023, WuXi Biologics is suppo...
Manufacturing Covered Outsourced, In-House Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexi...
* The added capacity will further enhance WuXi Biologics' commercial manufacturing capabilities i... 2024-01-08 17:524428 WuXi Biologics Named to 2023 Dow Jones Sustainability World Index * Identified as a global sustainability leader by S&P Global * Committed to generating long-term... ...
Revenue in USD billion, and CAGR from 2023 to 2030 Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends Segments covered Source, product, disease category, manufacturing, region Regional scope North America; Europe; Asia Pacific; Middle East & Africa; ...